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Objectives: To assess the seroprevalence and associated risk factors of toxoplasmosis
among HIV patients in Agaro Town Health Center of Jimma zone.
Methods: Convenient sampling was used to collect blood samples from 135 patients
attending anti-retroviral therapy from February to March 2015. Serum samples were
tested for anti-Toxoplasma gondii (T. gondii) antibody by using latex agglutination test.
Structured questionnaire was used to collect data on socio-demographic and risk factors
associated with toxoplasmosis.
Results: Overall seroprevalence of toxoplasmosis was 80.7% (109/135, CI: 74.04–
87.36). In multivariate analysis signiﬁcant association was observed between anti-
T. gondii seropositivity and raw meat consumption (OR: 3.514, CI: 1.167–10.581,
P = 0.025), knowledge about toxoplasmosis (OR: 5.225, CI: 1.382, P = 0.015) and sex
(OR: 4.023, CI: 1.382–19.762, P = 0.015).
Conclusions: Immuno compromised patients showed high rate of seropositivity and
thus, it is highly advisable to introduce routine anti-T. gondii antibodies serological
screening test prior to ART commencement.1. Introduction
Toxoplasma gondii (T. gondii) is an obligate intracellular
protozoan parasite that can cause toxoplasmosis in animals and
humans [1]. Feline species is the deﬁnitive host and plays a
central role in the epidemiology of T. gondii infections by
shedding resistant oocysts to the environment and thus serving
as a signiﬁcant source of infection for food animals and
humans [2]. It has been estimated that one-third of the world
human population is infected with toxoplasmosis and the inci-
dence rate of 400–4000 congenital toxoplasmosis cases per year
has been reported [3]. The principal route of acquisition of
infections are raw or under cooked meat, vegetable or other
feed or water, soil contaminated with oocyst and vertical
transmission [4]. Among these sources of infection, raw or
under cooked meat consumption has been reported to account
for more than 30%–60% [5]. Toxoplasmosis has been
considered as a major public health problem among immune-compromised and pregnant women. It has been reported that
the prevalence is higher in warm and humid environment [6].
Pregnant women with acute infection during pregnancy are at
risk of exposing the unborn to congenital infection [7]. Wide
geographic variation in the prevalence of latent Toxoplasma
infection have been reported across the world in Latin
America, parts of Eastern/Central Europe, the Middle East,
parts of south-east Asia and Africa 30%–75% [8].
Geographical variation of prevalence of toxoplasmosis has
been reported in different parts of the world: in United State
15% of childbearing age of women are infected with T. gondii
[9], 44% in pregnant women in France [10], greater than 60%
in Indonesia [8] and less than 8.38% in Eastern China [11].
Literatures indicate that T. gondii are asymptomatic in
immune-competent persons (Studenicova et al., 2006) but in
immune-compromised individuals as CD4+ T cell lymphocyte
count decrease, reactivation of the latent T. gondii infection fol-
lows causing life threatening disease known as toxoplasmic en-
cephalitis [12–14]. Prevalence rate of Toxoplasma infection among
HIV positive individuals across the world has been found to vary
from 3% to 97% [15,16]. According to the report of UNAIDS,
2011 Ethiopia ranks higher in HIV/AIDS prevalence and about
1.5 million people are infected and live with the virus. The
seroprevalence of toxoplasmosis among HIV individualser the CC BY-NC-ND license (http://
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Minch Hospital [16], 87.4% in Bahir Dar [17] and 60% in South
West Ethiopia Mettu Karl hospital [18].
Routine monitoring of T. gondii antibodies has been gaining
great importance in immune-compromised individuals though it
is not a routine practice in different health care centers of
Ethiopia. Even the existing majority of seroprevalence studies
are limited to HIV/AIDS patients alone with little emphasis to
associated risk factors. Furthermore, there has been no document
of toxoplasmosis seroprevalence study in Agaro town. There-
fore, the objective of this study was to detect the level of
prevalence of latent toxoplasmosis in HIV positive patients
registered and under follow-up by health professionals. In
addition, it was to assess socio-demographic risk factors asso-
ciated with this infection and forward recommendations that will
improve health service delivery.
2. Materials and methods
2.1. Study design and area
The study design was cross-sectional based in public health
center and convenient sampling was used based on inclusion
criteria of patient's willingness to participate in the study from
list of record book of the health center attending anti-retroviral
therapy (ART) at Agaro town health center from February to
March 2015. Agaro town is located in south western Ethiopia,
in Oromia National Regional State, Jimma zone, Agaro Wor-
eda, at a distance of 396 km from Addis Ababa. Its astro-
nomical location is 7 490 North Latitude and 36 East
Longitude at an elevation ranging from 880 m to 3360 m above
seas level (source Agaro city administration). The area receives
mean annual rainfall of about 1530 mm that comes from the
long and short rainy season and the mean annual temperature
ranges from 25 C to 30 C. Agaro town has a total population
of 28273.
2.2. Study population and sample size
The study populations were human immunodeﬁciency virus
(HIV) positive patients who were on follow up at Agaro town
health center for ART. Presently 706 HIV (457 females and 249
males) positive patients attending anti-retroviral therapy. The
total sample size was 135; calculated using Thrusﬁeld [19]
formula based on prevalence of 88.2% taken from a previous
study conducted in Arba Minch Hospital [16], 0.05 margin of
error (d) and at conﬁdence level of 95%. Accordingly, one
month data of patients visiting the health center for therapy
and counseling was used to recruit participants of this study.2.3. Data collection
About 5 mL of venous blood without anticoagulant was
aseptically collected by trained medical laboratory technician
following standard procedure from 135 HIV positive patients.
Serum was separated and stored at −20 C until the analyses was
conducted at Microbiology laboratory of Jimma University.
Trained ART attendant nurse interviewed the participants using
structured and pretested questionnaire to collect socio-
demographic characteristics and risk factors associated with
T. gondii infection.2.4. Serological method
A rapid slide agglutination Toxo-latex test (SPINREACT,
S.A/S.A.U Ctra Santa Coloma, Spain) was used strictly
following manufacturer instructions for qualitative and semi-
quantitative detection of anti-Toxoplasma antibodies with
analytical sensitivity of 4 IU/mL. Brieﬂy, the test contains latex
particles coated with soluble T. gondii antigen that are aggluti-
nated when mixed with serum samples containing antibodies
against Toxoplasma infection. In all sample analysis conducted
both positive and negative control tests were performed to
monitor the performance of the procedures and technical pro-
cedure was carried out correctly. The kit has diagnostic sensi-
tivity and speciﬁcity of 96.1% and 89.6%, respectively.
2.5. Data management and analysis
Data was recorded and coded in excel spread sheet before
analysis using statistical software SPSS version 22. Descriptive
statistics was used to summarize the data and hence, the prev-
alence of toxoplasmosis was calculated as the number in study
population testing positive to serological test divided by the total
study unit tested. A logistic regression model was used to check
the association of the disease toxoplasmosis with potential risk
factors. Non-collinear variables that presented P < 0.05 in uni-
variable analysis were offered to the multivariable regression
model. The strength of association was calculated using odds
ratio at 95% CI. P < 00.05 was considered as statistically
signiﬁcant.
2.6. Ethical approval
Ethical approval was obtained from our University research
ethical review committee and it was in accordance with the
ethical standards of our institutional research committee and
with the 1964 Helsinki declaration and its later amendments or
comparable ethical standards.
3. Result
3.1. Socio-demographic characteristics of the study
participants
Among 706 HIV positive patients attending ART, 135
(84.4%) was included in this study and the percentage of male
and female attendees was 43.7% and 56.3%, respectively.
Regardless of the disease condition, the mean age of the par-
ticipants was (33.83 ± 11.11) years (Table 1).
3.1.1. Seroprevalence of T. gondii infection
The overall seroprevalence of T. gondii infection in this study
was 80.7% (109/135, CI: 0.740–0.874). Seroprevalence of
T. gondii in relation to different socio-demographic factors is
presented in Table 1.
3.1.2. Risk factors associated with T. gondii infection
The bivariate logistic regression analysis showed a signiﬁcant
association between seropositivity to anti-T. gondii antibodies
and presence of cat, raw meat consumption, knowledge about
T. gondii and sex (Table 1). In multivariate logistic regression
analysis, factors such as knowledge about toxoplasmosis, sex
Table 1
Distribution of T. gondii infection along with demographic characteristics
of HIV patients (n = 135).
Risk factors HIV patients
Total −ve (n, %) +ve (n, %)
Age (years)
15–24 16 4 (25.0) 12 (75.0)
25–36 74 17 (22.9) 57 (77.1)
36–48 27 6 (22.2) 21 (77.8)
>48 18 3 (16.7) 15 (83.3)
Educational status
Illiterate 39 5 (12.8) 34 (87.2)
Literate 96 21 (19.3) 75 (78.1)
Sex
Male 59 19 (32.2) 40 (67.7)
Female 76 7 (9.21) 69 (90.8)
Place residence
Rural 76 11 (14.5) 65 (85.5)
Urban 59 15 (25.4) 44 (74.6)
Raw meat eating
Yes 82 8 (9.8) 74 (90.2)
No 53 18 (34.0) 35 (66.0)
Owing cat
Yes 65 7 (10.8) 58 (89.2)
No 26 19 (73.1) 7 (26.9)
Hand wash
Yes 50 8 (16.0) 42 (84.0)
No 85 18 (21.2) 67 (78.8)
Raw vegetable
Yes 69 13 (18.8) 56 (81.2)
No 66 13 (19.7) 53 (80.3)
Knowledge about T. gondii
Yes 46 3 (6.5) 43 (93.5)
No 89 23 (25.8) 66 (74.2)
Raw milk consumption
Yes 45 7 (15.6) 38 (84.4)
No 90 19 (21.1) 71 (78.9)
Religion
Muslim 83 14 (16.9) 69 (83.1)
Orthodox 41 10 (24.4) 31 (75.6)
Protestant 11 2 (18.2) 9 (81.8)
Table 3
Risk factors associated with T. gondii infection among HIV patients
(n = 135).
Seroprevalence 95% CI for
EXP (B)
Risk factors −ve
(n, %)
+ve
(n, %)
OR 95% CI Lower Upper P
Age (years)
15–24 4 (25.0) 12 (75.0) 1
25–36 17 (22.9) 57 (77.1) 1.033 0.259 4.129 0.963
37–48 6 (22.2) 21 (77.8) 0.340 0.079 1.472 0.149
>48 3 (16.7) 15 (83.3) 3.000 0.279 32.209 0.364
Educational status
Illiterate 5 (12.8) 34 (87.2) 1
Literate 21 (19.3) 75 (78.1) 1.904 0.662 5.474 0.232
Sex
Male 19 (32.2) 40 (67.7) 1
Female 7 (9.21) 69 (90.8) 4.682 1.811 12.108 0.001
Place residence
Rural 11 (14.5) 65 (85.5) 0.496 0.209 1.181 0.113
Urban 15 (25.4) 44 (74.6) 1
Raw meat eating
Yes 8 (9.8) 74 (90.2) 4.757 1.887 11.995 0.001
No 18 (34.0) 35 (66.0) 1
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seropositivity (Table 2).
Considering different age groups, the prevalence of T. gondii
infection among age groups greater than 48 years was the
highest. The prevalence in age category 15–24, 25–36, 37–48
and above 48 were 75% (CI: 0.279–32.209), 77.1% (CI: 0.259–
4.129), 77.8% (CI: 0.079–1.472) and 83.3% (CI: 0.279–32.209),Table 2
Multivariate analysis of independent predictor of T. gondii infection
among HIV patients (n = 135).
Risk factors OR 95% CI P
Presence of cat
Yes 1.194 0.376–3.793 0.764
No 1
Knowledge about toxoplasmosis
No 5.225 1.382–19.762 0.015
Yes 1
Sex
Female 4.023 1.447–11.185 0.008
Male 1
Consumption of raw meat
Yes 3.514 1.167–10.581 0.025
No 1respectively and level of infection was observed to increase with
age. However, there was no statistically signiﬁcance association
(P > 0.05) observed between seropositivity and the different age
groups. Moreover, there was no statistically signiﬁcant associ-
ation (P > 0.05) between seroprevalence of Toxoplasma infec-
tion and level of education, hand washing, residence, religions,
raw vegetable and milk consumption (Table 3).
It was observed that 48.1% of the participants had domestic
cat at their home. Among HIV patients owning cat, 89.2% (CI:
1.200–7.940) were seropositive for Toxoplasma infection.
Assessment of raw meat eating habit revealed that majority
(60.7%) had the experience of eating raw meat. Among those
with raw meat eating habit, the seroprevalence of T. gondii
infection was 89.2% (CI: 1.887–11.995). In addition, knowledge
about toxoplasmosis has strong association with T. gondii
seroprevalence and the percentage of participants who had no
knowhow about toxoplasmosis was 65.9%. Among those who
has no knowledge about T. gondii, 93.5% (CI: 1.413–17.661)
was seropositive. Regarding sex of participants, 56.4% were
female attending HIV anti-retroviral therapy. The prevalence of
anti-T. gondii seropositivity was signiﬁcantly higher in females
than males (P = 0.001).Presence of cat at home
Yes 7 (10.8) 58 (89.2) 3.087 1.200 7.940 0.019
No 19 (73.1) 7 (26.9) 1
Hand wash
Yes 8 (16.0) 42 (84.0) 0.709 0.283 1.775 0.463
No 25 (33.8) 49 (66.2) 1
Raw vegetable
Yes 13 (18.8) 56 (81.2) 0.946 0.402 2.227 0.900
No 13 (19.7) 53 (80.3) 1
Raw milk consumption
Yes 7 (15.6) 38 (84.4) 0.688 0.266 1.1783 0.442
No 19 (21.1) 71 (78.9) 1
Knowledge about T. gondii
Yes 3 (6.5) 43 (93.5) 1
No 23 (25.8) 66 (74.2) 4.995 1.413 7.661 0.013
Religion
Muslim 14 (16.9) 69 (83.1) 0.913 0.178 4.690 0.913
Orthodox 10 (24.4) 31 (75.6) 0.629 0.252 1.571 0.321
Protestant 2 (18.2) 9 (81.8) 1
+ve: positive, −ve: negative.
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Toxoplasma is an opportunistic parasite with grave public
health impact in immuno compromised individuals. Acute
infection of T. gondii results in IgM anti-T. gondii antibody
response followed by enduring solid immunity IgG anti-T. gondii
antibody which indicate chronic infection. Chronic infection of
T. gondii develops encephalitis in HIV positive patients [20]
especially in those individuals with CD4+ T lymphocytes count
level descend below 100 cells/mL [21]. Our study showed that
T. gondii antibody in HIV positive individuals attending ART
was 80.7%. This seroprevalence rate was high and is in
agreement with previous studies conducted in different agro-
ecological zones of Ethiopia [16–18,22].
The higher seroprevalence Esrates documented in this study
might be because of individuals close interaction with cat as a
pet animal, low level of awareness about means and route of
transmission and poor hygienic conditions. However, the vari-
ation in seropositivity across different regions might be attrib-
uted to rate of reactivation of latent infection tissue
toxoplasmosis when reduced cellular immunity in HIV patients
(Zhou et al., 2011) [23] and other socio-demographic factors
such as, age of the study participants, type of test method
used for detection of antibodies, feeding habit and living
standard of individuals are some of the factors responsible for
the variability of seroprevalence of toxoplasmosis in different
agro-ecological zones across the globe. For instance, 19.9%
in Malaysia (Brandon-Mong et al., 2015) [24], 28.5% in
woman in Democratic republic of Congo, 64.8% in western
Romania (Olariu et al., 2015) [25], 18.2% Southern Iran [26],
46% in Mozambique [27], 38.7% in Nigeria [28] and 54% in
Uganda [29].
The seroprevalence of T. gondii antibodies in pre-ART as
described also previously by different researchers [16,17] was
higher than post-ART of this study. This could be possibly
due to convalescing the immune status of patients, thus mini-
mizing the incidence of opportunistic infections [30].
It has been documented that in immune-compromised in-
dividuals a previously acquired latent infection can lead to
reactivation of toxoplasmosis causing severe encephalitis in
about 40% of HIV patients and 10%–30% mortality was re-
ported [31]. In view of this fact, almost all seroprevalence studies
conducted so far including the present study, mainly focused on
measuring the magnitude of antibody against latent infection and
yet encephalitis is the most important sequel. This emphasizes
on the need for further study on prevalence of encephalitis in
this area and elsewhere for proper management of the cases at
health centers.
In this study, latent toxoplasmosis seroprevalence was found
to increase with age and the difference was not statistically
signiﬁcant. This ﬁnding is in agreement with reports [1,16,32].
This might be due to increased risk of exposure to infection
with increasing age. In contrast, the report of [33] indicates
signiﬁcant association between seropositivity and age of
patients.
The common traditional taboo of Ethiopia is raw/under
cooked meat consumption accounts four times more likely
seropositivity for toxoplasmosis. This ﬁnding is consistent with
the reports of [16,17,22,34]. However, Muluye et al. [34] reported
the absence of statistically signiﬁcant association between
seroprevalence of T. gondii infection and the habit of raw or
under cooked meat consumption.This inconsistency of raw meat consumption in predicting
the seroprevalence of T. gondii in individuals depends on
seroprevalence of T. gondii in meat producing animals which is
70.48% in sheep, 58.3% in goat in central Ethiopia [35] and
3.6% in cattle in Tanzania [36], 64% in chicken in Ghana [37].
Furthermore, the area is warmer and humid environment
which is favorable climate for survival of the oocyst to
maintain its lifecycle. As a result of this fact there is a
possible contamination of the environment with T. gondii
oocyst excreted by house or street cats available in the area.
Our study revealed that contaminated environment with cat
excreted oocyst is three times more likely for T. gondii
antibodies seropositivity and this ﬁnding is in agreement with
previous report of [17] and in contrast, with the ﬁnding of
Yesuf and Melese [18] showed no association of presence of
cat with T. gondii seropositivity.
Preponderance of the study participants had no knowledge
about toxoplasmosis which is one of the independent predictor
for the seroprevalence of T. gondii. Even though some of the
participants had knowledge about the parasite, they did not
know the potential predisposing factors and role of cat in the
epidemiology of the toxoplasmosis. Our study also revealed that
the odds of T. gondii seropositivity were four times higher in
female in contrast with previous ﬁnding (Shimelis et al., 2009).
The study area is well known for its cash crop type of Agri-
culture whereby gardening and cropping is conducted by women
which is the main contributing factor for the high seroprevalence
of the disease in women. The ratio of female to male currently
attending ART at Agaro health center is 1.8:1 this might be
another attributing factor for the activation of latent toxoplas-
mosis higher in women.
The overall seroprevalence of T. gondii infection antibodies
among HIV patients was high and some potential independent
risk factors are signiﬁcantly associated with seropositivity of
T. gondii infection. Furthermore, raw meat consumption is a
potential source of the parasites and the recommendation should
be to avoid raw meat consumption to prevent possible ingestion
of viable cysts in meat which modulate immune system
conversely decrease CD4+ cells leading to activation of the
latent toxoplasmosis.
Considering this fact, we recommend toxoplasmosis
chemoprophylaxis in all HIV positive individuals to prevent
encephalitis. Other hygienic procedures such as hand washing
after gardening/farming to minimize the contamination of oocyst
need to be included in counseling package of patients. Knowl-
edge, attitude and practice about toxoplasmosis were low and
thus, education of the public is needed to create good awareness
about T. gondii transmission and risk factors. Moreover, it is
highly advisable for health ofﬁcers in charge to include routine
serological screening test for determination of anti-T. gondii
antibodies among HIV infected individuals pre-ART.
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